PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26325N0083DO SINGLE DOSE radiopharmaceuticals — Pharmalogic Holdings Corp

Pharmalogic Holdings Corp holds $3.9M across 20 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award under parent 36C26320D0038. PoP ended Feb 28, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Network Contract Office 23 (36C263)
Awarding office
Pharmalogic Holdings Corp
Recipient
Feb 28, 2025
PoP end
$228K
Obligated
$228K
Potential
325412
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Pharmalogic Holdings Corp — $90

Contract facts

Federal
Contract number36C26325N0083
Also listed as36C263-25-N-0083
Also listed as36C26320D0038-36C26325N0083
AgencyNetwork Contract Office 23 (36C263)
Awarding officeNetwork Contract Office 23 (36C263)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentPharmalogic Holdings Corp
CAGE7GAD2
UEIHVFXH4DBMXF2
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36C26320D0038
Place of performanceFORT MEADE SD
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition After Exclusion Of Sources
PoP startOct 1, 2024
PoP end (current)Feb 28, 2025
Obligated$228K
Current value$228K
Potential value$228K

DO SINGLE DOSE RADIOPHARMACEUTICALS is a federal award for Network Contract Office 23 (36C263) held by Pharmalogic Holdings Corp. Estimated value $228K ($228K obligated). Current period of performance ends Feb 28, 2025. Place of performance: FORT MEADE SD.

Recompete timing

Public
Past PoP end (540 days ago)

Current PoP ended Feb 28, 2025 (540 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Pharmalogic Holdings Corp$3.9M obligated across 20 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$3.9M · 100% of firm total
Open full company profile

Related awards

Same parent · incumbent
36C26326N0165
RADIOPHARMACEUTICALS
$200K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26325N0083?

36C26325N0083 (DO SINGLE DOSE radiopharmaceuticals) is a Network Contract Office 23 (36C263) award with a potential value of $228K, currently held by Pharmalogic Holdings Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C263-25-N-0083?

36C263-25-N-0083 is the dashed form of PIID 36C26325N0083 (DO SINGLE DOSE radiopharmaceuticals), held by Pharmalogic Holdings Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26325N0083?

Network Contract Office 23 (36C263) awarded 36C26325N0083 to Pharmalogic Holdings Corp (potential $228K).

Who is the incumbent on 36C26325N0083?

Pharmalogic Holdings Corp is the incumbent with $3.9M across 20 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2025.

When does Pharmalogic Holdings Corp’s 36C26325N0083 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 28, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26325N0083